Effect of vaginal misoprostol application for cervical softening in pregnancy interruption before ten weeks of gestation

Acta Obstetricia et Gynecologica Scandinavica

Volumn 75, Issue 1, 1996, Pages 54-56

  Fiçcioǵlu, Cem ^a   Taşdemir, Muhat ^b,c   Taşdemir, Seval ^a  

^a Division of Urogynecology   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Pregnancy interruption; Vaginal misoprostol

Indexed keywords

MISOPROSTOL; PROSTAGLANDIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CURETTAGE; DOUBLE BLIND PROCEDURE; FEMALE; FETOPLACENTAL UNIT; FETUS; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; INDUCED ABORTION; INTRAVAGINAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UTERINE CERVIX DILATATION; UTERUS BLEEDING;

EID: 0030070482     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.3109/00016349609033284     Document Type: Article

References (9)

1. Fonseca W, Alencar AJC, Mota FSB, Coelho HLL. Misoprostol and congenital malformations. Lancet 1991; 338: 56.
2. Bungalho A, Bigue C, Almedia L, Bergström S. Pregnancy interruption by vaginal misoprostol. Gynecol Obstet Invest 1993; 34: 226-9.
3. Bungalho A, Bigue C, Almedia L, Bergström S. Application of vaginal misoprostol before cervical dilatation to facilitate first-trimester pregnancy interruption. Obstet Gynecol 1994; 83: 729-31.
4. Molin A. Risk of damage to the cervix by dilatation for first trimester induced abortion by suction aspiration. Gynecol Obstet Invest 1993; 35: 152-4.
5. Rodger MW, Baird DT. Induction of therapeutic abortion in early pregnancy with mifepriston in combination with prostaglandin pessary. Lancet 1987; ii: 1415-8.
6. Bygdeman M, Swahn ML. Progesterone receptor blockade effect on uterine activity in early pregnancy. Contraception 1985; 32: 45-51.
7. Rabe T, Basse H, Thuro H, Kiesel L, Runnebaum B. Action of the PGEI methyl analogue misoprostol on the pregnant human uterus in the first trimester. Geburtshilfe Frauenheilkd 1987; 47: 324-31.
8. Committee on Safety of Medicines. Misoprostol (Cytotec) reports of uterine bleeding and diarrhoea. Cur Prob 1989; 27: 2-3.
9. Kotsonis FN, Dodd DC, Regnier B, Kohn FE. Preclinical toxicology profile of misoprostol. Dig Dis Sci 1985: 30(suppl): 1425-65.